AVD American Vanguard

AMVAC Chemical Acquires Bromacil Herbicide Business Assets from Bayer Crop Science

AMVAC Chemical Corporation, a wholly-owned subsidiary of American Vanguard Corporation (NYSE: AVD), today announced the purchase of the Bromacil herbicide business in the United States and Canada from Bayer Crop Science (“Bayer”). This transaction is unrelated to the acquisition of Monsanto by Bayer, and financial terms of the agreement were not disclosed.

The assets being purchased include the Bromacil trademarks and product registrations for sale of Hyvar® and Krovar® in the USA and Canada. In order to ensure a seamless transfer from Bayer to AMVAC, Bayer will continue to market and provide customer support for these products until the end of September 2018.

Bromacil is a broad spectrum residual herbicide used for non-agricultural industrial vegetation control and on many crops, such as pineapples, citrus, agave and asparagus. Marketed under the Hyvar® and Krovar® brands, Bromacil herbicides are valued and long established weed control tools. AMVAC previously purchased these brands from DuPont Crop Protection in 2015 for markets outside of US and Canada including Japan, Thailand, Mexico, Cost Rica and Brazil.

Eric Wintemute, Chairman and CEO of American Vanguard commented: “These proven weed management products will strengthen our competitive position in serving many niche crop markets and also allow us to expand AMVAC’s participation in the industrial vegetation management business. Along with other initiatives that we are pursuing, acquiring these Bromacil herbicide assets will enhance the breadth of our domestic herbicide portfolio. We have a history of excellent working relationships with Bayer and are delighted to be carrying this successful product line forward.”

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

EN
21/06/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on American Vanguard

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

American Vanguard Corp: 1 director

A director at American Vanguard Corp bought 12,000 shares at 5.970USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...

 PRESS RELEASE

American Vanguard Withdraws Dacthal Registration

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD) today announced that, following its decision in April 2024 to voluntarily stop sales of Dacthal herbicide products, the Company has submitted to the Environmental Protection Agency (“EPA”) voluntary cancellation requests for all of its federal registrations of those products. Those registrations are currently the subject of an emergency suspension order that was issued by EPA on August 6, 2024. In connection with its action, the Company made the following statements. While the Company continues to question E...

 PRESS RELEASE

American Vanguard Reports Q2 2024 Results

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD) today announced financial results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights – versus Second Quarter 2023: Net sales of $128.2 million v. $132.8 million Adjusted EBITDA1 of $6.2 million v. $10.7 million Earnings per share of $(0.42) v. $(0.04) First Half of 2024 Financial Highlights – versus First Half of 2023: Net sales of $263.4 million v. $257.7 million Adjusted EBITDA of $21.7 million v. $22.2 million Earnings per diluted share of $(0.36) v. $0...

 PRESS RELEASE

American Vanguard Schedules 2024 Second Quarter Earnings Release and C...

NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- American Vanguard Corporation (NYSE: AVD), today announced that it will report financial results for the second quarter ended June 30, 2024, on Thursday, August 8, 2024, after the close of the stock market. Tim Donelly, Acting CEO, David T. Johnson, VP, CFO and Treasurer, and Mark Bassett, Director will conduct a conference call focusing on operating performance and financial results at 4:30 pm ET / 1:30 pm PT on August 8, 2024. Interested parties may participate in the call by dialing 201-493-6744, please dial in 10 minutes before the scheduled start...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch